| Autor: |
Caramanna I; Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1118, PK 1Y 176, 1081 HZ, Amsterdam, The Netherlands.; Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Klein M; Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1118, PK 1Y 176, 1081 HZ, Amsterdam, The Netherlands. m.klein@amsterdamumc.nl.; Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. m.klein@amsterdamumc.nl., van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Idbaih A; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France., Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) & Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany., Taphoorn MJB; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.; Haaglanden Medical Centre, The Hague, The Netherlands., Dirven L; Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.; Haaglanden Medical Centre, The Hague, The Netherlands., Bottomley A; Quality of Life Department, European Organization for Research and Treatment of Cancer, Brussels, Belgium., Reijneveld JC; Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands. |
Full text from SpringerLink